Emergent BioSolutions Inc.·4

Mar 5, 9:19 PM ET

Perl Jessica 4

4 · Emergent BioSolutions Inc. · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
Perl Jessica
SVP, General Counsel, Corp Sec
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-03-05$8.44/sh6,465$54,56561,004 total
  • Award

    Employee Stock Option (Right to buy)

    [F2]
    2026-03-03+46,702142,647 total
    Exercise: $8.99Exp: 2033-03-02Common Stock (46,702 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
  • [F2]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact|2026-03-05

Documents

1 file
  • 4
    wk-form4_1772763573.xmlPrimary

    FORM 4